VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ HbA1c between 7.1% and 11.0%, inclusive            │ HbA1c between 7.1% and 11.0%, inclusive            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have participated in this study previously, or any │ Have participated in this study previously, or any │     100 │
│ other study using exenatide or GLP-1 analogs       │ other study using exenatide or GLP-1 analogs       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have participated in an interventional, medical,   │ Have participated in an interventional, medical,   │     100 │
│ surgical, or pharmaceutical study within 30 days   │ surgical, or pharmaceutical study within 30 days   │         │
│ of screening                                       │ of screening                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have characteristics contraindicating metformin or │ Have characteristics contraindicating metformin or │     100 │
│ sulfonylurea use                                   │ sulfonylurea use                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have been treated with exogenous insulin for more  │ Have been treated with exogenous insulin for more  │     100 │
│ than 1 week within the 3 months prior to screening │ than 1 week within the 3 months prior to screening │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have used drugs for weight loss within 1 month of  │ Have used drugs for weight loss within 1 month of  │     100 │
│ screening                                          │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body Mass Index (BMI) \>21 kg/m\^2 and \<35        │ Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2    │      96 │
│ kg/m\^2                                            │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Treated with a stable dose of one of the following │ Treated with a stable dose of one of the following │      99 │
│ for at least 3 months prior to screening: \*       │ for at least 3 months prior to screening: * >=1000 │         │
│ \>=1000 mg/day immediate-release metformin; or     │ mg/day immediate-release metformin; or metformin   │         │
│ metformin \>=1000 mg/day and sulfonylurea; or      │ >=1000 mg/day and sulfonylurea; or                 │         │
│ sulfonylurea/metformin combination therapy         │ sulfonylurea/metformin combination therapy         │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 75 Years │ Have characteristics contraindicating metformin or │      32 │
│                                   │ sulfonylurea use                                   │         │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 21 Years │ Have characteristics contraindicating metformin or │      34 │
│                                   │ sulfonylurea use                                   │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 86.1
OverAll Ratio: 90.55
